Topics
Glioblastoma | Treatment | Clinical trials | Intraoperative
Home > Publications > Topics > Glioblastoma > Treatment > Clinical trials > Intraoperative
*Giordano FA, Ganslandt O, Münter MW, Combs SE, Diehl C,
Meyer B, Herrlinger U, Schneider M, Kahl KH, Shiban E, Goenka A,
Schulder M, Lucas A, Plans G, Brehmer S, Ruder AM, García-Cabezas
S, Solivera J, Cifarelli CP, Wenz F, Sarria GR, Pope WB, Layer JP,
Tsien CI, Petrecca K; INTRAGO-II Study Group.
Dose
escalation with intraoperative radiotherapy in newly diagnosed
glioblastoma (INTRAGO-II): an open-label, multicentre, randomised,
controlled, phase 3 trial.
Lancet
Oncol. 2026 Jun 29;27(7):864-878. doi:
10.1016/S1470-2045(26)00235-4. PMID:
42372746. Trial
registration ID: NCT02685605. ˍ